Avidity Partners Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34,188	Closed	-$25.3M	–	101
2020 Q4	$25.3M	Buy	34,188 +563	+2%	+$416K	0.82%	43
2020 Q3	$23.3M	Buy	33,625 +9,369	+39%	+$6.5M	1.08%	27
2020 Q2	$20.6M	Buy	24,256 +11,068	+84%	+$9.39M	1.32%	28
2020 Q1	$4.72M	Buy	+13,188	New	+$4.72M	0.65%	45